Close Menu

NEW YORK – Laboratory for Advanced Medicine said this week that the US Food and Drug Administration has granted breakthrough device designation for its liquid biopsy blood test to detect the presence of liver cancer at Stage I.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.